Home
Conditions
Lung Neoplasms

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

4,211 public trials 1,007 recruiting studies

Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Completed

Radiofrequency Ablation of Pulmonary Tumors Response Evaluation

NCT00690703

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations: UCLA Medical Center Los Angeles, California, United States

University of New South Wales Sydney, Australia

University Hospital Essen Essen, Germany

Ludwig-Maximilians University München, Germany

View Trial Details

Completed

Safety Study of Radiotherapy and Concurrent Erlotinib (Tarceva®) for Brain Metastases From a Non-Small Cell Lung Cancer

NCT00536861

Conditions: Brain Diseases, Brain Metastases, Brain Neoplasms, +15 more
Locations: VU University Medical Center Amsterdam, Netherlands

View Trial Details

Completed

Study of Oxaliplatin and Gemcitabine With or Without Bevacizumab to Treat Advanced Non-Small Cell Lung Cancer

NCT00217282

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Mount Sinai Medical Center Miami Beach, Florida, United States

View Trial Details

Completed

Ph I:Bevacizumab + Chemotherapy in Pts w/Malig Pleural Effusion Due to Adv NSCLC

NCT00250978

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Preoperative Twice Daily Chemoradiation in Addition to Chemotherapy Prior to Surgery in Stage III Non-Small Cell Lung Cancer (NSCLC)

NCT00176137

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Not specified

View Trial Details

Completed

Randomized Phase III-Study in Stage IIIb and IV Non-Small-Cell Lung Cancer. Sequential Single-Agent vs. Double-Agent vs. Triple-Agent Therapy.

NCT00148395

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Klinikum Kassel GmbH Kassel, Germany

View Trial Details

Completed

Three Combinations Of Docetaxel And Irinotecan For Recurrent Or Metastatic Non Small Cell Lung Cancer

NCT00139711

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations: Pfizer Investigational Site Alzano Lombardo, BG, Italy

Pfizer Investigational Site Gravedona, CO, Italy

Pfizer Investigational Site Crema, CR, Italy

Pfizer Investigational Site Gorgonzola, MI, Italy

View all 15 locations

View Trial Details

Completed

Study of Alimta® (Pemetrexed) Plus VELCADE® (Bortezomib) or Alimta Alone or VELCADE Alone in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Prior Therapy

NCT00343720

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +15 more
Locations: Hopital de Jolimont Haine-Saint-Paul, Belgium

View Trial Details

Completed

Diagnostic Effectiveness of Virtual Bronchoscopy

NCT00001515

Conditions: Actinomycetales Infections, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +44 more
Locations: Warren G. Magnuson Clinical Center (CC) Bethesda, Maryland, United States

View Trial Details

Completed

Metronomic Oral Vinorelbine in Patients With Metastatic Tumors

NCT00278070

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +22 more
Locations: Henry Dunant Hospital Athens, Greece

Sotiria Hospital Athens, Greece

University Hospital "Attikon" Athens, Greece

Agii Anargiri Cancer Hospital Athens, Greece

View Trial Details

Lung Neoplasms

Lung Neoplasms trial results

Related conditions